Prices and Clinical Benefit of National Price-Negotiated Anticancer Medicines in China
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-2027
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Prices and Clinical Benefit of National Price-Negotiated Anticancer Medicines in China ; volume:40 ; number:7 ; day:29 ; month:6 ; year:2022 ; pages:715-724 ; date:7.2022
PharmacoEconomics ; 40, Heft 7 (29.6.2022), 715-724, 7.2022
- Urheber
-
Zhang, Yichen
Wei, Yuxuan
Li, Huangqianyu
Chen, Yixuan
Guo, Yiran
Han, Sheng
Shi, Luwen
Guan, Xiaodong
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40273-022-01161-7
- URN
-
urn:nbn:de:101:1-2022083119080363046985
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zhang, Yichen
- Wei, Yuxuan
- Li, Huangqianyu
- Chen, Yixuan
- Guo, Yiran
- Han, Sheng
- Shi, Luwen
- Guan, Xiaodong
- SpringerLink (Online service)
Ähnliche Objekte (12)
Negotiated transfer prices
Health technology assessment-informed pricing negotiation in China: higher negotiated price for more effective targeted anticancer medicines?
Dynamic competition in negotiated price markets
Exploring the Heterogeneous Effects of State Price Transparency Laws on Charge Prices, Negotiated Prices, and Operating Costs
Predictors of negotiated prices for new drugs in Germany
Search frictions and market power in negotiated price markets
Predictors of negotiated prices for new drugs in Germany
The usage and costs of national drug price-negotiated anticancer medicines in a first-tier city in Northeast China: a study based on health insurance data
Price variation among different brands of anticancer medicines available in hospital pharmacies of Nepal
Mergers when prices are negotiated: Evidence from the hospital industry
Governing the market through prices: The state and controls on the price of medicines in France
Analysis of prices paid by low-income countries - how price sensitive is government demand for medicines?
Negotiated transfer prices
Health technology assessment-informed pricing negotiation in China: higher negotiated price for more effective targeted anticancer medicines?
Dynamic competition in negotiated price markets
Exploring the Heterogeneous Effects of State Price Transparency Laws on Charge Prices, Negotiated Prices, and Operating Costs
Predictors of negotiated prices for new drugs in Germany
Search frictions and market power in negotiated price markets
Predictors of negotiated prices for new drugs in Germany
The usage and costs of national drug price-negotiated anticancer medicines in a first-tier city in Northeast China: a study based on health insurance data
Price variation among different brands of anticancer medicines available in hospital pharmacies of Nepal
Mergers when prices are negotiated: Evidence from the hospital industry
Governing the market through prices: The state and controls on the price of medicines in France
Analysis of prices paid by low-income countries - how price sensitive is government demand for medicines?
Negotiated transfer prices
Health technology assessment-informed pricing negotiation in China: higher negotiated price for more effective targeted anticancer medicines?
Dynamic competition in negotiated price markets
Exploring the Heterogeneous Effects of State Price Transparency Laws on Charge Prices, Negotiated Prices, and Operating Costs
Predictors of negotiated prices for new drugs in Germany
Search frictions and market power in negotiated price markets
Predictors of negotiated prices for new drugs in Germany
The usage and costs of national drug price-negotiated anticancer medicines in a first-tier city in Northeast China: a study based on health insurance data
Price variation among different brands of anticancer medicines available in hospital pharmacies of Nepal
Mergers when prices are negotiated: Evidence from the hospital industry
Governing the market through prices: The state and controls on the price of medicines in France